Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts

L. Richeldi, B. M. Bergamini, F. Vaienti
European Respiratory Journal 2008 32: 524-525; DOI: 10.1183/09031936.00014508
L. Richeldi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. M. Bergamini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Vaienti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

We read with interest the paper by Leyten et al. 1, which appeared in the June 2007 issue of the European Respiratory Journal (ERJ). Leyten et al. 1 showed that prior tuberculin skin tests (TST) do not induce false-positive QuantiFERON®-TB Gold in-tube (QFT-GIT) assay results when evaluated in the days immediately following TST administration. In the same issue of the ERJ, Naseer et al. 2 reported the results of a study of 10 subjects without risk for tuberculosis infection, who were tested with QFT-GIT and the T-SPOT.TB assay (Oxford Immunotec, Abingdon, UK) before, 48 h and 6 weeks after TST administration. Naseer et al. 2 confirmed the results of Leyten et al. 1 in the first days following skin testing; however, after 6 weeks, three out of nine individuals turned from negative to positive with QFT-GIT, and none of the subjects turned from negative to positive with T-SPOT.TB. On this basis, Naseer …

View Full Text
PreviousNext
Back to top
View this article with LENS
Vol 32 Issue 2 Table of Contents
European Respiratory Journal: 32 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts
L. Richeldi, B. M. Bergamini, F. Vaienti
European Respiratory Journal Aug 2008, 32 (2) 524-525; DOI: 10.1183/09031936.00014508

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts
L. Richeldi, B. M. Bergamini, F. Vaienti
European Respiratory Journal Aug 2008, 32 (2) 524-525; DOI: 10.1183/09031936.00014508
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Statement of interest
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Treatable traits approach in interstitial lung disease
  • Reply: Treatable traits approach in interstitial lung disease
  • Reply: TB screening in migrants to the EU/EEA and UK
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society